BIOPHARMA
By
Is Stanford’s MedAgentBench Setting the New Gold Standard for AI in Clinical Care?
Key Highlights AI benchmarking moves beyond knowledge tests: Unlike earlier evaluations that focused on exams like the USMLE,…
Is Novartis Deepening Its Bet on AI-Enabled Molecular Glue Degraders Through an Expanded Collaboration With Monte Rosa?
Novartis AG (SIX: NOVN; NYSE: NVS), a global leader in immunology and targeted therapies, has broadened its partnership…
Could Johnson & Johnson’s MARIPOSA Trial with RYBREVANT® + LAZCLUZE® Transform First-Line EGFR-Mutated NSCLC Treatment?
Key Highlights: Clinical Breakthrough in EGFR-Mutated NSCLCJohnson & Johnson’s Innovative Medicine segment has announced positive results from the…
Can Novo Nordisk’s New Semaglutide and Obesity Pipeline Data at EASD 2025 Redefine ‘Food Noise’ Control, Body Composition, and Cardiovascular Outcomes?
Key Highlights: Scientific Momentum at EASD 2025Novo Nordisk will present 35 abstracts across its diabetes and obesity portfolio…
Could Cohere’s New Paris Office Accelerate AI Adoption Across Europe’s Healthcare and Biopharma Sector?
Key Insights: Expanding Footprint in Europe Cohere, a Canadian AI firm known for developing large language models and…
Can GHX’s AI-Driven Supply Chain Solutions Transform How Hospitals Tackle Disruptions?
Key Highlights AI reshaping healthcare supply chains: Unlike retail or tech, healthcare requires flawless delivery—any delay can directly…
